Your session is about to expire
← Back to Search
Memory Self-Efficacy Training for Mild Cognitive Impairment
Study Summary
This trial will explore how memory self-efficacy, a trait that can be improved with training, affects older adults' memory performance and brain activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can new individuals take part in this trial?
"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, initiated on August 1st 2023, is presently recruiting patients. A total of 28 participants are sought from one medical facility."
What is the current number of individuals taking part in this experiment?
"Confirmed. Per the information on clinicaltrials.gov, this medical trial is actively searching for participants and was first made available to the public on August 1st 2023. The data has been revised as recently as December 4th 2023 with a goal of recruiting 28 patients from one site."
Is the recruitment process for this trial including individuals over sixty years of age?
"This clinical trial welcomes patients aged between 60 and 80. Additionally, there are 25 studies for individuals under 18 years old and 574 studies that involve participants over 65."
What are the objectives of this experimental program?
"The primary focus of this trial, which spans a period of 6 weeks with pre and post intervention measurements, is assessing neurological biomarkers in the default mode network. Secondary outcomes encompass story recall to gauge episodic memory capacity; list recall as an indicator for working memory; and face-name pairs that evaluate associative memory - all of these are trained performance tasks customised within the training protocol."
Do I satisfy the requirements to participate in this clinical investigation?
"This medical trial needs 28 participants aged 60-80, with mild cognitive impairment and the following additional criteria: recent subjective memory complaints; impaired standardized cognitive testing scores below age norms; a score of less than 25 on Montreal Cognitive Assessment; 1.5 standard deviations below typical performance in memory tests; unimpaired daily activities & general cognition; fluent English reading/writing/speaking abilities, and right handedness."
Share this study with friends
Copy Link
Messenger